Call for Abstracts Opening
September 15, 2026
May 17 - 20, 2027 Montréal, QC, Canada
The 11th International Symposium on Hereditary Breast and Ovarian Cancer brings together the global scientific community to reflect on three decades of progress and chart the future of genetic medicine.
September 15, 2026
November 15, 2026
Join over 800 colleagues, clinicians and researchers from over 40 countries for the tenth edition of this event, recognized as one of the leading international scientific conferences on hereditary cancer.
Experience stimulating exchanges and valuable networking opportunities with experts from across North America and abroad.
Discover practical insights, new developments in BRCA 1/2 research, and evolving clinical care options.
International biennial symposium
750+ participants
40+ countries represented
Four-day scientific program
Dedicated industry exhibition
Networking with global leaders in hereditary cancer research and care
Concurrent one-day public conference for patients, families and advocates on May 18th
Cancer Science Institute of Singapore, Singapore
The Marla Miller Memorial Lecture
Institute of Cancer Research, London, United Kingdom
Mayo Clinic, USA
Stay tuned for our complete list of invited speakers!
Mark your calendars leading up to the premier clinical oncology symposium.
New this year: oral and poster abstracts have the same deadline.
–
What our global community is saying
“Incredible knowledge sharing. Impressive speaker line-up—they truly are key thought leaders in the field.”
“I appreciated the mix of basic science, clinical application and psychosocial lectures.”
“Very stimulating to have so many international attendees. Interesting to see differences in practice.”
“Spectacular conference. Honestly one of the best.”
Whether you are a primary care physician, genetic counselor, researcher, nurse, or other healthcare professional, BRCA 2027 offers unparalleled opportunities for learning and professional growth.